An evolutionary view of drug-receptor interaction: the bioamine receptor family.

The large molecular diversity of receptors and their subtypes means that the pharmacologist is faced with many puzzling characterization questions. First, the molecular diversity of the receptors is deciphered only in part by a pharmacological approach, which precludes a satisfactory receptor classification based solely on pharmacological characteristics. Second, the physiological counterpart of the numerous subtypes of receptors specifically activated by single endogenous ligands remains unclear. Here, Philippe Vernier and colleagues use the example of the bioamine G protein-coupled receptors to show that many of the apparent inconsistencies that emerge from pharmacological and molecular characterizations of receptors can be better understood if the evolutionary history of the receptors is taken into account.

[1]  P. Fishman,et al.  Desensitization of the human beta 1-adrenergic receptor. Involvement of the cyclic AMP-dependent but not a receptor-specific protein kinase. , 1991, The Journal of biological chemistry.

[2]  S. Liggett,et al.  Human alpha 2-adrenergic receptor subtype distribution: widespread and subtype-selective expression of alpha 2C10, alpha 2C4, and alpha 2C2 mRNA in multiple tissues. , 1993, Molecular pharmacology.

[3]  T. Ohta,et al.  Synonymous and nonsynonymous substitutions in mammalian genes and the nearly neutral theory. , 1995, Journal of molecular evolution.

[4]  B. Kobilka,et al.  Identification of a single amino acid residue responsible for the binding of a class of beta-adrenergic receptor antagonists to 5-hydroxytryptamine1A receptors. , 1992, Molecular pharmacology.

[5]  D. Hoyer,et al.  Partial agonists, full agonists, antagonists: dilemmas of definition. , 1993, Trends in pharmacological sciences.

[6]  S. Brenner,et al.  Analysis of the dopamine receptor family in the compact genome of the puffer fish Fugu rubripes. , 1995, Genomics.

[7]  R. Hen,et al.  Of mice and flies: commonalities among 5-HT receptors. , 1992, Trends in pharmacological sciences.

[8]  E. Fischer Einfluss der Configuration auf die Wirkung der Enzyme , 1894 .

[9]  Wen-Hsiung Li,et al.  Fundamentals of molecular evolution , 1990 .

[10]  D. Hoyer,et al.  A proposed new nomenclature for 5-HT receptors. , 1993, Trends in pharmacological sciences.

[11]  J. Baldwin The probable arrangement of the helices in G protein‐coupled receptors. , 1993, The EMBO journal.

[12]  J. Thorner,et al.  Model systems for the study of seven-transmembrane-segment receptors. , 1991, Annual review of biochemistry.

[13]  G Vriend,et al.  A common step for signal transduction in G protein-coupled receptors. , 1994, Trends in pharmacological sciences.

[14]  Jean Clobert,et al.  Aspects of the genesis and maintenance of biological diversity , 1996 .

[15]  E. Parker,et al.  A Single Amino Acid Difference Accounts for the Pharmacological Distinctions Between the Rat and Human 5‐Hydroxytryptamine1B Receptors , 1993, Journal of neurochemistry.

[16]  D Rodbard,et al.  Drug efficacy at guanine nucleotide-binding regulatory protein-linked receptors: thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand. , 1992, Molecular pharmacology.

[17]  B. O'dowd,et al.  Heterogeneous tissue-specific transcription of dopamine receptor subtype messenger RNA in rat brain. , 1994, Brain research. Molecular brain research.

[18]  H. Niznik,et al.  The Dopamine D1D Receptor , 1995, The Journal of Biological Chemistry.

[19]  R. Lefkowitz,et al.  Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. , 1993, Trends in pharmacological sciences.

[20]  D. Mackay Interpretation of relative potencies, relative efficacies and apparent affinity constants of agonist drugs estimated from concentration-response curves. , 1990, Journal of theoretical biology.

[21]  P. Molinoff,et al.  International Union of Pharmacology nomenclature of adrenoceptors. , 1994, Pharmacological reviews.

[22]  J. Regan,et al.  Selective coupling of alpha 2-adrenergic receptor subtypes to cyclic AMP-dependent reporter gene expression in transiently transfected JEG-3 cells. , 1993, Molecular pharmacology.

[23]  William R. Pearson,et al.  Molecular characterization of α1- and α2-adrenoceptors , 1991 .

[24]  G. Milligan,et al.  Mechanisms of multifunctional signalling by G protein-linked receptors. , 1993, Trends in pharmacological sciences.

[25]  M. Keen Testing models of agonism for G protein-coupled receptors. , 1991, Trends in pharmacological sciences.

[26]  P. Strange New insights into dopamine receptors in the central nervous system , 1993, Neurochemistry International.

[27]  P P Humphrey,et al.  International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). , 1994, Pharmacological reviews.

[28]  Peter N. Devreotes,et al.  G protein-linked signaling pathways control the developmental program of dictyostelium , 1994, Neuron.

[29]  K. Kuma,et al.  Functional constraints against variations on molecules from the tissue level: slowly evolving brain-specific genes demonstrated by protein kinase and immunoglobulin supergene families. , 1995, Molecular biology and evolution.

[30]  S. Watson,et al.  Receptor subtypes or species homologues: relevance to drug discovery. , 1993, Trends in pharmacological sciences.

[31]  J. B. Walsh,et al.  How often do duplicated genes evolve new functions? , 1995, Genetics.

[32]  J. Felsenstein Phylogenies from molecular sequences: inference and reliability. , 1988, Annual review of genetics.

[33]  B. Kobilka,et al.  A point mutation in the seventh hydrophobic domain of the alpha 2 adrenergic receptor increases its affinity for a family of beta receptor antagonists. , 1991, The Journal of biological chemistry.